HealthStream Inc

HealthStream Inc(HSTM)股票分析

$33.130

-0.610 (-1.84%)收盤時

Loading chart…
最高
34.180
開盤
33.950
成交量加權均價
33.33
成交量
207.26K
市值
846.58M
最低
32.670
成交金額
6.91M
企業價值/稅息折舊攤銷前利潤(TTM)
12.70

HealthStream, Inc. provides platform-delivered workforce solutions. Its solutions include Software-as-a-Service (SaaS), subscription-based applications used by healthcare organizations to meet a range of their workforce development needs around learning, clinical development, credentialing, and scheduling. Its content libraries allow customers to subscribe to an array of courseware, which includes content from healthcare and nursing associations, medical and healthcare publishers, and other content providers. Its scheduling solutions provide customers with real-time visibility into clinical staff scheduling. Its credentialing, privileging, and enrollment solution, CredentialStream, provides customers a user experience with a continual stream of enhancements, evidence-based content, and curated data, which provides healthcare organizations with tools to support the provider lifecycle management from recruiting, application submission, verification of licensure, and other credentials.

AI 分析 of HealthStream Inc (HSTM)

持有

HealthStream Inc is currently trading at $33.13, which is above the analyst target price of $27, indicating it may be overvalued at this time. The RSI is at 64.45, suggesting it is nearing overbought territory, while the forward P/E ratio is 33.78, which is relatively high compared to industry averages. The recent earnings report showed a significant EPS of $0.23, up from $0.18 year-over-year, reflecting strong profitability. However, insider selling has increased by 146.37%, which raises concerns about insider confidence in the stock's future performance.

分析師評級(9)

-24.54% 下跌空間
持有
4 買進
5 持有
0 賣出
目前: 33.13
最低
25.00
平均
25.00
最高
25.00

Canaccord

2026-07-21

目標價

$27

持有

Canaccord

2026-05-06

目標價

$24

持有

Canaccord

2026-02-25

目標價

$21

持有

Canaccord

2026-01-08

目標價

$25

持有

Canaccord

2025-08-07

目標價

$28

持有

估值指標

HealthStream Inc(HSTM)目前預期本益比為 33.78,5 年平均預期本益比為 54.95。

預期本益比

合理
5 年均值 P/E
54.95
目前P/E
33.78
高估
78.72
低估
31.17

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
11.58
目前EV/EBITDA
12.70
高估
13.23
低估
9.92

預期股價營收比

高估
5 年均值 P/S
2.62
目前P/S
3.00
高估
3.00
低估
2.24

Alphio AI 對 HSTM 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%HSTM

$27.38

情境價格

基

基準

基準 · 50%HSTM

$25.98

情境價格

悲

悲觀

悲觀 · 25%HSTM

$21.36

情境價格

持有 HSTM 的大戶

P

Punch & Associates Investment Management, Inc.

+ 持有HSTM

-5.54%

3個月報酬率

事件時間軸

2026-08-11 (ET)

08:30:00

Humana Collaborates with HealthStream to Expand Healthcare Services in Indiana

2026-08-03 (ET)

17:00:00

Company Reports Q2 Revenue of $83.7M

17:00:00

Now Projects 2026 Adjusted EBITDA of $74M-$78M

2026-05-04 (ET)

16:40:00

Company Reports Q2 Revenue of $81.2M

16:40:00

HealthStream Promotes Michael M. Collier to Chief Operating Officer

資訊

HSTM 常見問題 —— 由 Alphio AI 解答

HealthStream, Inc. provides platform-delivered workforce solutions. Its solutions include Software-as-a-Service (SaaS), subscription-based applications used by healthcare organizations to meet a range of their workforce development needs around learning, clinical development, credentialing, and scheduling. Its content libraries allow customers to subscribe to an array of courseware, which includes content from healthcare and nursing associations, medical and healthcare publishers, and other content providers. Its scheduling solutions provide customers with real-time visibility into clinical staff scheduling. Its credentialing, privileging, and enrollment solution, CredentialStream, provides customers a user experience with a continual stream of enhancements, evidence-based content, and curated data, which provides healthcare organizations with tools to support the provider lifecycle management from recruiting, application submission, verification of licensure, and other credentials. It operates in the Technology sector (SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ET industry).

HealthStream Inc is currently trading at $33.13, which is above the analyst target price of $27, indicating it may be overvalued at this time. The RSI is at 64.45, suggesting it is nearing overbought territory, while the forward P/E ratio is 33.78, which is relatively high compared to industry averages. The recent earnings report showed a significant EPS of $0.23, up from $0.18 year-over-year, reflecting strong profitability. However, insider selling has increased by 146.37%, which raises concerns about insider confidence in the stock's future performance.

9 analysts cover HSTM: 4 rate it Buy, 5 Hold and 0 Sell. The average price target is 25.00.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易